Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

635
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
635
Schizophrenia01:17

Schizophrenia

964
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
964
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

607
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
607
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

613
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
613
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

471
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
471
What are Lipids?01:38

What are Lipids?

220.2K
Overview
220.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depressive comorbidity in type 2 Diabetes: Prevalence and associated factors.

La Tunisie medicale·2026
Same author

Sex-specific association of IDO1 gene with schizophrenia and imbalanced levels of cytokines and neuroactive kynurenine metabolites in relapsed patients.

European archives of psychiatry and clinical neuroscience·2025
Same author

Mental health, coping and related risk factors during the first 2 years of the COVID-19 pandemic in children: Nationally representative, multi-wave, cross-sectional results from 12 countries from the global COH-FIT study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2025
Same author

Toll-like receptor 3 (TLR 3) polymorphisms predisposition to schizophrenia and bipolar disorder.

Molecular biology reports·2025
Same author

Genetic Predisposition of TLR 1 and TLR 6 Polymorphisms to Schizophrenia Onset and Prediction of Treatment Response.

Biochemical genetics·2025
Same author

Factors associated with attention-deficit/hyperactivity disorder among Tunisian children.

Frontiers in psychiatry·2025

Related Experiment Video

Updated: Feb 3, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.4K

Lipid profile in schizophrenia: case control study.

Ahmed Mhalla, Walid Bel Hadj Salah, Rim Mensi

    La Tunisie Medicale
    |October 17, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Schizophrenia patients exhibit higher cholesterol and LDL-C levels, increasing cardiovascular risk. Factors like age, male gender, and alcohol use worsen dyslipidemia, while depressive symptoms are linked to poorer lipid profiles.

    More Related Videos

    NMR Spectroscopy as a Robust Tool for the Rapid Evaluation of the Lipid Profile of Fish Oil Supplements
    08:54

    NMR Spectroscopy as a Robust Tool for the Rapid Evaluation of the Lipid Profile of Fish Oil Supplements

    Published on: May 1, 2017

    26.8K
    Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
    13:08

    Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia

    Published on: December 2, 2015

    9.5K

    Related Experiment Videos

    Last Updated: Feb 3, 2026

    A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
    05:51

    A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

    Published on: June 15, 2011

    26.4K
    NMR Spectroscopy as a Robust Tool for the Rapid Evaluation of the Lipid Profile of Fish Oil Supplements
    08:54

    NMR Spectroscopy as a Robust Tool for the Rapid Evaluation of the Lipid Profile of Fish Oil Supplements

    Published on: May 1, 2017

    26.8K
    Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
    13:08

    Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia

    Published on: December 2, 2015

    9.5K

    Area of Science:

    • Cardiovascular Health
    • Psychiatric Disorders
    • Metabolic Syndrome

    Background:

    • Cardiovascular diseases are a leading cause of mortality in schizophrenia patients.
    • Dyslipidemia is a significant risk factor contributing to cardiovascular complications in this population.
    • Understanding lipid profiles in schizophrenia is crucial for risk stratification and management.

    Purpose of the Study:

    • To compare lipid profiles (total cholesterol, triglycerides, HDL-C, LDL-C) between schizophrenia patients and healthy controls.
    • To identify associations between lipid parameters and demographic, clinical, and treatment characteristics in schizophrenia patients.

    Main Methods:

    • A case-control study involving 78 schizophrenia patients and 68 healthy controls.
    • Serum lipid parameters (TC, TG, HDL-C, LDL-C) were measured.
    • Demographic data and clinical assessments using PANSS, CGI, GAF, and Calgary depression scale were collected.

    Main Results:

    • Schizophrenia patients showed significantly higher total cholesterol (TC) and LDL-C levels compared to controls.
    • Prevalence of hypercholesterolemia and low-density hyperlipoproteinemia was significantly higher in patients.
    • Age (≥35), male gender, and alcohol consumption were associated with dyslipidemia; cannabis use correlated with lower TG; depressive symptoms worsened lipid parameters.

    Conclusions:

    • Schizophrenia patients are at increased risk of dyslipidemia, exacerbated by alcohol and tobacco use, older age, and male gender.
    • Paranoid schizophrenia and positive symptoms were associated with less dyslipidemia, whereas depressive symptoms indicated poorer lipid profiles.
    • Regular lipid monitoring, lifestyle interventions, and tailored therapeutic strategies are essential to reduce cardiovascular morbidity and mortality in schizophrenia patients, with a focus on those with depressive symptoms.